ZomedicaCorp. (NYSE: ZOM) stock jumped 14.46% to 0.205 in the after-market session. Yet, there does notseem to be any company-specific news that has prompted Ideanomics’ share priceto increase today, and investors will want to take that as a warning sign.
Nevertheless, on November 12, 2020, the firm with the marketcapitalization of 101.02M officially posted consolidated financial reports for the thirdquarter ended September 30, 2020.
Zomedica(NYSE: ZOM) revealed that Research and development spending for the quarter
ended September 30, 2020, was about $2.7 million, compared to approximately $1.0million for the three months ended September 30, 2019, a rise of approximately1.7 million, or 181percent. The rise was largely attributed to a milestonecost of $2.0 million under ourproduction and supply dealwith QorvoBiotechnologies, LLC., compensated in part by reducing about $237,000 in agreedexpenditures, materials, regulatory fees, and consultancy fees.
Moreover,a veterinary health organization developing point-of-care testing products fordogs and cats revealed on November 13, 2020, a plan to deliver the TRUFORMAa point-of-care diagnostic platform on March 30, 2021.
